Close

Ratings by Aegis Capital (Nathan Weinstein)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/12/2022 Evogene Ltd EVGN Maintain Buy
(N/A)
 
 
  Details
7/12/2022 Stereotaxis STXS New Coverage Buy
(N/A)
2.06
(1.79)
-13.11% Details
6/2/2022 Immunic Inc. IMUX Maintain Buy
(N/A)
 
 
  Details
5/16/2022 DarioHealth Corp. DRIO Maintain Buy
(N/A)
 
 
  Details
5/10/2022 Harrow Health HROW Maintain Buy
(N/A)
 
 
  Details
3/29/2022 Trevi Therapeutics TRVI New Coverage Buy
(N/A)
2.16
(1.90)
-12.04% Details
3/22/2022 Entera Bio ENTX Maintain Buy
(N/A)
 
 
  Details
3/8/2022 Enveric Biosciences ENVB Downgrade Hold
(Buy)
0.25
(4.79)
1816% Details
2/15/2022 SCYNEXIS SCYX Maintain Buy
(N/A)
 
 
  Details
1/26/2022 DarioHealth Corp. DRIO Maintain Buy
(N/A)
 
 
  Details
12/7/2021 Chemomab Therapeutics CMMB New Coverage Buy
(N/A)
7.43
(2.31)
-68.91% Details
11/1/2021 Inspira Technologies Oxy B.H.N. Ltd. IINN Maintain Buy
(N/A)
 
 
  Details
9/30/2021 Kintara Therapeutics, Inc KTRA Maintain Buy
(N/A)
 
 
  Details
9/24/2021 Harrow Health HROW New Coverage Buy
(N/A)
9.68
(11.91)
23.04% Details
9/22/2021 Cidara Therapeutics CDTX Maintain Buy
(N/A)
 
 
  Details
9/9/2021 XOMA, Ltd. XOMA Maintain Buy
(N/A)
 
 
  Details
8/17/2021 atai Life Sciences N.V ATAI Maintain Buy
(N/A)
 
 
  Details
7/29/2021 Evogene Ltd EVGN New Coverage Buy
(N/A)
2.94
(0.75)
-74.49% Details
7/8/2021 atai Life Sciences N.V ATAI New Coverage Buy
(N/A)
17.50
(3.41)
-80.51% Details
7/8/2021 Enveric Biosciences ENVB New Coverage Buy
(N/A)
2.08
(4.79)
130.29% Details
6/29/2021 XOMA, Ltd. XOMA New Coverage Buy
(N/A)
32.31
(17.15)
-46.92% Details
6/16/2021 Kindred Biosciences KIN Downgrade Hold
(Buy)
6.34
(9.25)
45.9% Details
6/8/2021 Oramed Pharma ORMP Maintain Buy
(N/A)
 
 
  Details
4/15/2021 Immunic Inc. IMUX New Coverage Buy
(N/A)
14.52
(3.73)
-74.31% Details
4/12/2021 SCYNEXIS SCYX Maintain Buy
(N/A)
 
 
  Details
3/22/2021 Entera Bio Ltd ENTX New Coverage Buy
(N/A)
0.00
(1.05)
0% Details
3/15/2021 CohBar CWBR New Coverage Buy
(N/A)
1.44
(3.14)
118.06% Details
3/4/2021 Cidara Therapeutics CDTX New Coverage Buy
(N/A)
2.23
(0.65)
-70.85% Details
3/2/2021 MediWound Ltd MDWD New Coverage Buy
(N/A)
5.48
(1.42)
-74.09% Details
2/11/2021 Marrone Bio Innovations MBII Maintain Buy
(N/A)
 
 
  Details
2/8/2021 DarioHealth Corp. DRIO Maintain Buy
(N/A)
 
 
  Details
2/3/2021 Kintara Therapeutics, Inc KTRA Maintain Buy
(N/A)
 
 
  Details
1/26/2021 Greenwich LifeSciences GLSI New Coverage Buy
(N/A)
36.16
(9.81)
-72.87% Details
1/26/2021 Kindred Biosciences KIN Maintain Buy
(N/A)
 
 
  Details
10/19/2020 Biomerica BMRA Maintain Buy
(N/A)
 
 
  Details
10/8/2020 VistaGen Therapeutics VTGN New Coverage Buy
(N/A)
0.70
(0.16)
-77.14% Details
9/29/2020 Dynatronics DYNT Maintain Buy
(N/A)
 
 
  Details
9/16/2020 Avinger AVGR Maintain Buy
(N/A)
 
 
  Details
9/14/2020 Kintara Therapeutics, Inc KTRA New Coverage Buy
(N/A)
1.60
(0.13)
-91.88% Details
9/4/2020 Biomerica BMRA Maintain Buy
(N/A)
 
 
  Details
9/2/2020 Acasti Pharma ACST Downgrade Hold
(Buy)
0.22
(0.58)
163.64% Details
8/19/2020 VolitionRX VNRX Maintain Buy
(N/A)
 
 
  Details
8/17/2020 DarioHealth Corp. DRIO New Coverage Buy
(N/A)
16.50
(5.49)
-66.73% Details
8/14/2020 Marrone Bio Innovations MBII Maintain Buy
(N/A)
 
 
  Details
8/13/2020 Matinas BioPharma Holdings Inc. MTNB Maintain Buy
(N/A)
 
 
  Details
8/3/2020 Ekso Bionics EKSO Maintain Buy
(N/A)
 
 
  Details
7/13/2020 ImmuCell ICCC New Coverage Buy
(N/A)
5.55
(8.00)
44.14% Details
6/19/2020 Cardiovascular Systems CSII New Coverage Buy
(N/A)
33.98
(13.74)
-59.56% Details
5/15/2020 Avinger AVGR Maintain Buy
(N/A)
 
 
  Details
5/6/2020 VolitionRX VNRX New Coverage Buy
(N/A)
4.18
(1.67)
-60.05% Details
4/23/2020 SCYNEXIS SCYX Maintain Buy
(N/A)
 
 
  Details
4/2/2020 Amarin Corporation AMRN Maintain Buy
(N/A)
 
 
  Details
4/2/2020 Dynatronics DYNT Maintain Buy
(N/A)
 
 
  Details
3/23/2020 Anixa Biosciences ANIX New Coverage Buy
(N/A)
1.85
(4.91)
165.41% Details
3/11/2020 Oramed Pharma ORMP New Coverage Buy
(N/A)
3.61
(6.54)
81.16% Details
1/30/2020 Matinas BioPharma Holdings Inc. MTNB Maintain Buy
(N/A)
 
 
  Details
1/29/2020 Amarin Corporation AMRN Maintain Buy
(N/A)
 
 
  Details
1/24/2020 Dare Bioscience DARE Maintain Buy
(N/A)
 
 
  Details
1/9/2020 Matinas BioPharma Holdings Inc. MTNB New Coverage Buy
(N/A)
1.64
(0.69)
-57.93% Details
11/22/2019 Amarin Corporation AMRN Maintain Buy
(N/A)
 
 
  Details
11/11/2019 Stemline Therapeutics STML Maintain Buy
(N/A)
 
 
  Details
10/31/2019 Amarin Corporation AMRN New Coverage Buy
(N/A)
16.36
(1.28)
-92.18% Details
9/12/2019 Avinger AVGR New Coverage Buy
(N/A)
1.14
(1.29)
13.16% Details
9/9/2019 OpGen OPGN Maintain Buy
(N/A)
 
 
  Details
8/22/2019 Dare Bioscience DARE New Coverage Buy
(N/A)
0.79
(1.00)
26.58% Details
7/31/2019 SCYNEXIS SCYX New Coverage Buy
(N/A)
1.14
(2.53)
121.93% Details
7/24/2019 Marrone Bio Innovations MBII New Coverage Buy
(N/A)
1.37
(0.80)
-41.61% Details
7/9/2019 Acasti Pharma ACST New Coverage Buy
(N/A)
1.46
(0.22)
-84.93% Details
6/5/2019 Dynatronics DYNT New Coverage Buy
(N/A)
1.50
(0.52)
-65.33% Details
4/10/2019 Kindred Biosciences KIN New Coverage Buy
(N/A)
9.07
(9.25)
1.98% Details